Effect of Low Testosterone Levels on the Expression of Proliferator-Activated Receptor Alpha in Female Patients with Primary Biliary Cholangitis.
immune-mediated cholangitis
liver injury testosterone
peroxisome proliferator-activated receptor alpha
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
14 09 2023
14 09 2023
Historique:
received:
08
08
2023
revised:
05
09
2023
accepted:
12
09
2023
medline:
29
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Sex-dependent patterns in chronic immune-mediated cholangiopathies, like primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), remain poorly understood. Peroxisome proliferator-activated receptor alpha (PPAR-α), expressed in immune cells, plays a key role in innate defence. In this study, the relationship between PPAR-α expression in peripheral blood mononuclear cells (PBMCs), serum androgen levels, IFNγ production, and sex-dependent tendencies during the development of PBC and PSC was investigated. We confirmed that normal cholangiocytes respond to PPAR-α and inhibit the lipopolysaccharide-induced expression of IL-6, IL-1b, and TNFα. Compared with PSC patients, PPAR-α was downregulated, while IFNγ was upregulated, in the PBMCs of PBC patients. When the analysis was conducted on females only, there was no difference in PPAR-α, but IFNγ was elevated in females with PBC compared with those with PSC. Serum testosterone concentrations in females with PBC were below the normal range (regardless of age) and correlated positively with PPAR-α and negatively with IFNγ. While PPAR-α has been reported to be a target of miR-155 and miR-21, no correlations with these microRNAs were observed in the PBMCs. However, a positive correlation between miR-21 and IFNγ was observed. Our results showed suppressed PPAR-α expression accompanied by reduced testosterone levels in women with PBC, which should elicit interest in the role of testosterone in PBC development.
Identifiants
pubmed: 37759496
pii: cells12182273
doi: 10.3390/cells12182273
pmc: PMC10526765
pii:
doi:
Substances chimiques
MicroRNAs
0
PPAR alpha
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2013;8(2):e55694
pubmed: 23424637
Nat Immunol. 2010 Feb;11(2):141-7
pubmed: 19946272
Hum Reprod Update. 2014 Jan-Feb;20(1):76-105
pubmed: 24082040
J Immunol. 1999 Jan 1;162(1):35-40
pubmed: 9886367
J Clin Invest. 1977 Jun;59(6):1066-70
pubmed: 864003
Lancet. 2018 Jun 23;391(10139):2547-2559
pubmed: 29452711
Hepatology. 2015 Aug;62(2):635-43
pubmed: 25678132
J Immunol. 2015 Mar 15;194(6):2522-30
pubmed: 25672751
Am J Med Sci. 1995 Oct;310(4):158-60
pubmed: 7573120
Cells. 2022 Sep 15;11(18):
pubmed: 36139455
J Immunol. 2000 Jun 15;164(12):6237-43
pubmed: 10843676
Am J Physiol Gastrointest Liver Physiol. 2012 Nov 15;303(10):G1077-86
pubmed: 22961800
Lancet. 2020 Dec 12;396(10266):1915-1926
pubmed: 33308474
J Immunol. 1997 Jul 1;159(1):3-6
pubmed: 9200430
Mol Biol Cell. 2015 Aug 1;26(15):2845-57
pubmed: 26063731
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Metabolism. 2021 Jan;114:154338
pubmed: 32791172
J Clin Invest. 2017 Aug 1;127(8):3167-3176
pubmed: 28737505
Ann N Y Acad Sci. 2002 Jun;966:131-42
pubmed: 12114267
Eur J Obstet Gynecol Reprod Biol. 2002 Jul 10;103(2):154-7
pubmed: 12069739
Front Immunol. 2020 Jul 29;11:1567
pubmed: 32849531
Arch Neurol. 2007 May;64(5):683-8
pubmed: 17502467
J Clin Endocrinol Metab. 2009 Jun;94(6):2044-51
pubmed: 19318446
Front Immunol. 2015 Jan 29;6:19
pubmed: 25688245
Int J Mol Sci. 2018 Mar 14;19(3):
pubmed: 29538313
Cancer Res. 2010 Oct 15;70(20):8108-16
pubmed: 20813833
J Immunol. 2011 Sep 15;187(6):3362-73
pubmed: 21849676
Ann N Y Acad Sci. 1999 Jun 22;876:426-9
pubmed: 10415638
J Immunol. 2021 Sep 1;207(5):1322-1332
pubmed: 34341171
J Immunol. 2011 Sep 1;187(5):2233-43
pubmed: 21788445
J Hepatol. 2016 Jun;64(6):1378-87
pubmed: 26867493
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Arthritis Rheumatol. 2016 Apr;68(4):953-64
pubmed: 26556607
Cells. 2022 Mar 18;11(6):
pubmed: 35326489
Gut. 2016 Nov;65(11):1882-1894
pubmed: 26338827
Lipids Health Dis. 2018 Nov 14;17(1):256
pubmed: 30428868
Br J Rheumatol. 1996 Jun;35(6):568-73
pubmed: 8670579
Am J Physiol Gastrointest Liver Physiol. 2011 Dec;301(6):G981-91
pubmed: 21903763
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9505-10
pubmed: 22647601
FEBS Lett. 2003 Jul 10;546(2-3):237-40
pubmed: 12832047
J Exp Med. 2007 Feb 19;204(2):321-30
pubmed: 17261635
Int J Mol Sci. 2023 Mar 27;24(7):
pubmed: 37047274
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10355-60
pubmed: 21636785
J Immunol. 2001 Aug 15;167(4):2060-7
pubmed: 11489988